Global Molecular Diagnostics Market Size, Trends & Growth Opportunity, By Product & Services (Reagents & Kits, Instruments, and Software & Service), By Technology (Polymerase Chain Reaction (PCR), DNA Sequencing and NGS, Isothermal Nucleic Acid Amplification Technology, DNA Microarrays, In Situ Hybridization, and Others), By Application, By End User, By Region and Forecast from 2022-2027 2027
Global Molecular Diagnostics Market 
Global Molecular Diagnostics Market was valued at USD 21.2 billion in 2021 which is expected to reach at USD 34.6 billion by 2027 at a CAGR 6.97%. 
A molecular diagnostic technique is used to analyse and identify proteins or nucleic acids. This technique aids in the monitoring and diagnosis of diseases, as well as in determining which therapy should be administered to the patient. Furthermore, this technique provides quantitative measurements that inform energy stage of care and health condition management.
Market Drivers
Increased prevalence of infectious diseases such as COVId-19, influenza, HPV, HIV hepatitis, and tuberculosis is expected to drive the global molecular diagnostics market. Furthermore, advances in molecular diagnostics have facilitated disease detection, which will positively influence market growth over the forecast period. Furthermore, growing government and numerous organizations initiatives and findings for research and development in molecular diagnostics are expected to drive market growth during the forecast period. Furthermore, an increase in the prevalence of hospital-acquired infections and infectious diseases is expected to drive demand for molecular diagnostics during the forecast period.
Market Restraints
The major concerns that are expected to stymie the global molecular diagnostic market growth are delays in the approval of molecular diagnostic products and tests. The regulatory requirements for molecular diagnostics are becoming more stringent, which may limit market growth.
Impact of COVID-19
The global COVID-19 pandemic will increase demand for molecular diagnostics products and services. Furthermore, a sharp increase in the supportive regularity landscape for product development and launch, as well as an increase in the target patient population, will drive the global molecular diagnostic market growth.
Market Segmentation
The report has segmented global molecular diagnostics market according to the product and services such as Reagents & Kits, Instruments, and Software & Service, by technology such as Polymerase Chain Reaction (PCR), DNA Sequencing and NGS, Isothermal Nucleic Acid Amplification Technology, DNA Microarrays, In Situ Hybridization, and Others, by application such as Infectious Diseases, Oncology, Genetic Tests, and Others. Further, market is segmented into end user such as Hospital and Academics Laboratories, Reference Laboratories, and Others.
Regional Analysis
On the basis region global molecular diagnostics market is segmented into five regions including North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Over the forecast period, North America will hold the largest market share in the global molecular diagnostics market. Because of the region's growing geriatric population and easy access to advanced healthcare infrastructure. During this forecast period, Europe is the second largest region in the global molecular diagnostic market. Increased R&D investments and funds, as well as increased government support for the life sciences sector. Furthermore, due to developing economies such as India, China, and South Korea, Asia Pacific is the fastest growing market.
Market Key Players
Major Key players are listed in global molecular diagnostics market report including Abbott Laboratories, Qiagen, Illumina, Hologic, Grifols, Diasorin, Danaher Corporation, Biomérieux, Becton, Dickinson and Company, and Agilent Technologies
Market Taxonomy
By Products and Services
• Reagents & Kits
• Instrument
• Software & Service
By Technology
• Polymerase Chain Reaction (PCR)
• DNA Sequencing and NGS
• Isothermal Nucleic Acid Amplification Technology
• DNA Microarrays
• In Situ Hybridization
• Others
By Application
• Infectious Diseases
• Oncology
• Genetic Tests
• Others
By End User
• Hospital and Academics Laboratories
• Reference Laboratories
• Others
By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

Global Molecular Diagnostics Market 
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Molecular Diagnostics Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Molecular Diagnostics Market, By Product & Service
5.1 Y-o-Y Growth Comparison, By Product & Service 
5.2 Global Molecular Diagnostics Market Share Analysis, By Product & Service 
5.3 Global Molecular Diagnostics Market Size and Forecast, By Product & Service
5.3.1 Reagent & Kits
5.3.2 Instrument
5.3.3 Software & Service 
6 Global Molecular Diagnostics Market, By Technology
6.1 Y-o-Y Growth Comparison, By Technology
6.2 Global Molecular Diagnostics Market Share Analysis, By Technology
6.3 Global Molecular Diagnostics Market Size and Forecast, By Technology
6.3.1 Polymerase Chain Reaction (PCR) 
6.3.2 DNA Sequencing and NGS
6.3.3 Isothermal Nucleic Acid Amplification Technology
6.3.4 DNA Microarrays
6.3.5 In- Situ Hybridization
6.3.6 Others
7 Global Molecular Diagnostics Market, By Application
7.1 Y-o-Y Growth Comparison, By Application
7.2 Global Molecular Diagnostics Market Share Analysis, By Application
7.3 Global Molecular Diagnostics Market Size and Forecast, By Application
7.3.1 Infectious Diseases 
7.3.2 Oncology
7.3.3 Genetic Tests
7.3.4 Others
8 Global Molecular Diagnostics Market, By End User
8.1 Y-o-Y Growth Comparison, By End User
8.2 Global Molecular Diagnostics Market Share Analysis, By End User
8.3 Global Molecular Diagnostics Market Size and Forecast, By End User
8.3.1 Hospital and Academics Laboratories 
8.3.2 Reference Laboratories
8.3.3 Others
9Global Molecular Diagnostics Market, By Region
9.1 Global Molecular Diagnostics Market Share Analysis, By Region
9.2 Global Molecular Diagnostics Market Share Analysis, By Region
9.3 Global Molecular Diagnostics Market Size and Forecast, By Region
10 North America Molecular Diagnostics Analysis and Forecast (2022 – 2027)
10.1 Introduction
10.2 North America Molecular Diagnostics Product Market Share Analysis, By Product & Service
10.3 North America Molecular Diagnostics Product Market Size and Forecast, By Technology
10.4 North America Molecular Diagnostics Product Market Size and Forecast, By Application
10.5 North America Molecular Diagnostics Product Market Size and Forecast, By End User
10.6 North America Molecular Diagnostics Product Market Size and Forecast, By Country
10.6.1 U.S.
10.6.2 Canada
10.6.3 Mexico
11Europe Molecular Diagnostics Market Analysis and Forecast (2022 – 2027)
11.1 Introduction
11.2 Europe Molecular Diagnostics Product Market Share Analysis, By Product & Service 
11.3 Europe Molecular Diagnostics Product Market Size and Forecast, By Technology 
11.4 Europe Molecular Diagnostics Product Market Size and Forecast, By Application
11.5 Europe Molecular Diagnostics Product Market Size and Forecast, By End User
11.6 Europe Molecular Diagnostics Product Market Size and Forecast, By Country
11.6.1 Germany
11.6.2 France
11.6.3 UK
11.64. Rest of Europe
12Asia Pacific Molecular Diagnostics Market Analysis and Forecast (2022 – 2027)
12.1 Introduction
12.2 Asia Pacific Molecular Diagnostics Product Market Share Analysis, By Product & Service 
12.3 Asia Pacific Molecular Diagnostics Product Market Size and Forecast, By Technology  
12.4 Asia Pacific Molecular Diagnostics Product Market Size and Forecast, By Application
12.5 Asia Pacific Molecular Diagnostics Product Market Size and Forecast, By End User
12.6 Asia Pacific Molecular Diagnostics Product Market Size and Forecast, By Country
12.6.1 China
12.6.2 Japan
12.6.3 India
12.6.4. Rest of Asia Pacific
13Latin America Molecular Diagnostics Market Analysis and Forecast (2022 – 2027)
13.1 Introduction
13.2 Latin America Molecular Diagnostics Product Market Share Analysis, By Product & Service 
13.3 Latin America Molecular Diagnostics Product Market Size and Forecast, By Technology 
13.4 Latin America Molecular Diagnostics Product Market Size and Forecast, By Application
13.5 Latin America Molecular Diagnostics Product Market Size and Forecast, By End User
13.6 Latin America Molecular Diagnostics Product Market Size and Forecast, By Country
14Middle East Molecular Diagnostics Market Analysis and Forecast (2022 – 2027)
14.1 Introduction
14.2 Middle East Molecular Diagnostics Product Market Share Analysis, By Product & Service 
14.3 Middle East Molecular Diagnostics Product Market Size and Forecast, By Technology 
14.4 Middle East Molecular Diagnostics Product Market Size and Forecast, By Application
14.5 Middle East Molecular Diagnostics Product Market Size and Forecast, By End User
14.6 Middle East Molecular Diagnostics Product Market Size and Forecast, By Country
15Competitive Analysis
15.1 Competition Dashboard
15.2 Market share Analysis of Top Vendors
15.3 Key Development Strategies
16Company Profiles
16.1 Abbott Laboratories
16.1.1 Overview
16.1.2 Offerings
16.1.3 Key Financials
16.1.4 Business Segment & Geographic Overview
16.1.5 Key Market Developments
16.1.6 Key Strategies
16.2 Qiagen
16.2.1 Overview
16.2.2 Offerings
16.2.3 Key Financials
16.2.4 Business Segment & Geographic Overview
16.2.5 Key Market Developments
16.2.6 Key Strategies
16.3 Illumina
16.3.1 Overview
16.3.2 Offerings
16.3.3 Key Financials
16.3.4 Business Segment & Geographic Overview
16.3.5 Key Market Developments
16.3.6 Key Strategies
16.4 Hologic
16.4.1 Overview
16.4.2 Offerings
16.4.3 Key Financials
16.4.4 Business Segment & Geographic Overview
16.4.5 Key Market Developments
16.4.6 Key Strategies
16.5 Grifols
16.5.1 Overview
16.5.2 Offerings
16.5.3 Key Financials
16.5.4 Business Segment & Geographic Overview
16.5.5 Key Market Developments
16.5.6 Key Strategies
16.6 Diasorin
16.6.1 Overview
16.6.2 Offerings
16.6.3 Key Financials
16.6.4 Business Segment & Geographic Overview
16.6.5 Key Market Developments
16.6.6 Key Strategies
16.7 Danaher Corporation
16.7.1 Overview
16.7.2 Offerings
16.7.3 Key Financials
16.7.4 Business Segment & Geographic Overview
16.7.5 Key Market Developments
16.7.6 Key Strategies 
16.8 Biomérieux
16.8.1 Overview
16.8.2 Offerings
16.8.3 Key Financials
16.8.4 Business Segment & Geographic Overview
16.8.5 Key Market Developments
16.8.6 Key Strategies 
16.9 Becton, Dickinson and Company
16.9.1 Overview
16.9.2 Offerings
16.9.3 Key Financials
16.9.4 Business Segment & Geographic Overview
16.9.5 Key Market Developments
16.9.6 Key Strategies 
16.10 Agilent Technologies
16.10.1 Overview
16.10.2 Offerings
16.10.3 Key Financials
16.10.4 Business Segment & Geographic Overview
16.10.5 Key Market Developments
16.10.6 Key Strategies